Viewing Study NCT05359718



Ignite Creation Date: 2024-05-06 @ 5:33 PM
Last Modification Date: 2024-10-26 @ 2:31 PM
Study NCT ID: NCT05359718
Status: COMPLETED
Last Update Posted: 2024-02-08
First Post: 2021-03-08

Brief Title: The Psychological Impact of COVID-19 on Patients With Solid Malignancies A Single-Institution Survey Study
Sponsor: The Christie NHS Foundation Trust
Organization: The Christie NHS Foundation Trust

Study Overview

Official Title: The Psychological Impact of COVID-19 on Patients With Solid Malignancies A Single-Institution Survey Study
Status: COMPLETED
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PICO SM
Brief Summary: The COVID-19 pandemic and the subsequent government-imposed restrictions have undeniably resulted in unprecedented changes to the life of patients with cancer It has become more evident that patients with cancer may be at significant risk of higher morbidity and mortality when infected with SARS-CoV-2 which is understandably causing anxiety amongst both patients and their oncology team

This project is a single centre non-interventional observational prospective cohort study which aims to evaluate the impact of COVID-19 on the mental health and general wellbeing of patients diagnosed with solid malignancies by utilising a range of non-invasive questionnaires GAD-7 PHQ-9 PC-PTSD-5 WHO-5 and Wellbeing thermometer Data on patient demographics treatment and medical history and medical resource utilization will be obtained through a medical chart review at enrolment for up to 4 months Participants will be asked to complete five questionnaires regarding their mental health and wellbeing status during their routine clinic visits but no other additional tests or procedures will be undertaken for the study outside of their routine care

It is essential to understand both the short and long term psychological consequences of COVID-19 on cancer patients to better inform the institute and other regional and national stakeholders of the scale of the issue in order to recommend necessary measures and resources required to address this important issue
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None